SCIMEDX CORPORATION, USA is a highly flexible diagnostic company, with over 35 years’ experience in the area of IN Vitro Diagnostics (IVD).

   The strength of the organization is the collective diversified experiences of the personnel in many areas of diagnostics and biochemistry. We specialize in immunofluorescence, ELISA and membrane technologies for a variety of unique and routine autoimmune and infectious diseases, whereas the Scimedx combines product development, manufacturing and with a keen awareness of laboratory’s needs.

        SCIMEDX is confident in its ability to produce first-rate products for the medical device. Therefore, Scimedx extends its platforms for disease testing:

• The first was ImmuoCyt an FDA cleared & patented assay for bladder cancer.

Scimedx expanded its IFA and Latex Infectious assays by acquiring PANBIO for HHV, Dengue, West Nile.

Scimedx then went on to acquire Parasitology serology assays from IVD Research and Continuing for growth, Scimedx has finalized its rapid testing platform.

Scimedx is the de-facto manufacturer of IFA, ELISA, Agglutination tests, delivering solutions for disease testing worldwide.

 Certificates: ISO 9001, ISO13485, GMP-Certificate, FDA Registration and CE Mark.